Brief: VBI Vaccines Announces Q3 Loss Per Share Of $0.06
08/11/2021 13:10
Nov 8 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS AND
PROVIDES CORPORATE UPDATE
* Q3 REVENUE $100,000
* Q3 LOSS PER SHARE $0.06
* INITIAL PHASE 1B DATA EXPECTED Q1 2022 ASSESSING VBI-2905
AS A
SINGLE-DOSE BOOSTER IN PREVIOUSLY IMMUNIZED ADULTS
* $137.5 MILLION IN CASH AND CASH EQUIVALENTS AT END OF Q3
2021
Source text for Eikon: ID:nBw8xYQkla
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55